These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. RAR and RXR modulation in cancer and metabolic disease. Altucci L; Leibowitz MD; Ogilvie KM; de Lera AR; Gronemeyer H Nat Rev Drug Discov; 2007 Oct; 6(10):793-810. PubMed ID: 17906642 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of heteroarotinoids demonstrate structure specificity relationships. Benbrook DM; Subramanian S; Gale JB; Liu S; Brown CW; Boehm MF; Berlin KD J Med Chem; 1998 Sep; 41(19):3753-7. PubMed ID: 9733501 [TBL] [Abstract][Full Text] [Related]
7. Retinoid metabolism and its effects on the vasculature. Rhee EJ; Nallamshetty S; Plutzky J Biochim Biophys Acta; 2012 Jan; 1821(1):230-40. PubMed ID: 21810483 [TBL] [Abstract][Full Text] [Related]
8. [Metabolism of adipose tissue in normal humans and in various metabolic disorders. II. The adipose tissue in metabolic diseases]. Sezille G; Jaillard J; Biserte G Ann Biol Clin (Paris); 1970; 28(3):209-15. PubMed ID: 5478256 [No Abstract] [Full Text] [Related]
9. Synthesis of ring-oxidized retinoids as substrates of mouse class I alcohol dehydrogenase (ADH1). Domínguez M; Alvarez R; Martras S; Farrés J; Parés X; de Lera AR Org Biomol Chem; 2004 Nov; 2(22):3368-73. PubMed ID: 15534715 [TBL] [Abstract][Full Text] [Related]
10. The binding of synthetic retinoids to lipocalin beta-lactoglobulins. Riihimäki-Lampén LH; Vainio MJ; Vahermo M; Pohjala LL; Heikura JM; Valkonen KH; Virtanen VT; Yli-Kauhaluoma JT; Vuorela PM J Med Chem; 2010 Jan; 53(1):514-8. PubMed ID: 19938842 [TBL] [Abstract][Full Text] [Related]
12. Kinetics of human alcohol dehydrogenase with ring-oxidized retinoids: effect of Tween 80. Martras S; Alvarez R; Gallego O; Domínguez M; de Lera AR; Farrés J; Parés X Arch Biochem Biophys; 2004 Oct; 430(2):210-7. PubMed ID: 15369820 [TBL] [Abstract][Full Text] [Related]
13. [Studies on the structure-activity relationship of retinoids--Hansch analysis and 3D-OSAR studies on specific ligands of retinoid x receptor]. Huang N; Chu F; Guo Z Yao Xue Xue Bao; 1998 Jun; 33(6):442-8. PubMed ID: 12016914 [TBL] [Abstract][Full Text] [Related]
14. Irisin: a new molecular marker and target in metabolic disorder. Chen JQ; Huang YY; Gusdon AM; Qu S Lipids Health Dis; 2015 Jan; 14():2. PubMed ID: 25588692 [TBL] [Abstract][Full Text] [Related]
16. Current research and future developments in retinoids: oral and topical agents. Chandraratna RA Cutis; 1998 Feb; 61(2 Suppl):40-5. PubMed ID: 9787993 [TBL] [Abstract][Full Text] [Related]
17. Aldo-keto reductases in retinoid metabolism: search for substrate specificity and inhibitor selectivity. Porté S; Xavier Ruiz F; Giménez J; Molist I; Alvarez S; Domínguez M; Alvarez R; de Lera AR; Parés X; Farrés J Chem Biol Interact; 2013 Feb; 202(1-3):186-94. PubMed ID: 23220004 [TBL] [Abstract][Full Text] [Related]
18. Structure characteristics of natural and synthetic retinoids. Klaus M Methods Enzymol; 1990; 189():3-14. PubMed ID: 2292940 [No Abstract] [Full Text] [Related]
19. Design, synthesis and evaluation of retinoids with novel bulky hydrophobic partial structures. Amano Y; Noguchi M; Nakagomi M; Muratake H; Fukasawa H; Shudo K Bioorg Med Chem; 2013 Jul; 21(14):4342-50. PubMed ID: 23685180 [TBL] [Abstract][Full Text] [Related]